71
Berkhout, Daniel J.C., Klaassen, Patrick, Niemarkt, Hendrik J., de Boode, Willem P., Cossey, Veerle, van Goudoever, Johannes B., Hulzebos, Christiaan V., Andriessen, Peter, van Kaam, Anton H., Kramer, Boris W., van Lingen, Richard A., Vijlbrief, Daniel C., van Weissenbruch, Mirjam M., Benninga, Marc, de Boer, Nanne K.H., de Meij, Tim G.J.
2018
2018
72
73
74
75
Scholl, Joep H G, van Hunsel, Florence P A M, Hak, Eelko, van Puijenbroek, Eugène P
Veröffentlicht in: Scholl , J H G , van Hunsel , F P A M , Hak , E & van Puijenbroek , E P 2018 , ' A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands ' , Pharmcoepidemiology and Drug Safety , vol. 27 , no. 2 , pp. 199-205 . https://doi.org/10.1002/pds.4364;
2018
Veröffentlicht in: Scholl , J H G , van Hunsel , F P A M , Hak , E & van Puijenbroek , E P 2018 , ' A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands ' , Pharmcoepidemiology and Drug Safety , vol. 27 , no. 2 , pp. 199-205 . https://doi.org/10.1002/pds.4364;
2018
76
77
78
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
79
80